Alpro Pharmacy, a leading provider of healthcare solutions, announced that the Drug Control Authority, under the Ministry of Health Malaysia, has issued a circular on the cancellation and product recall of Pholcodine, an opioid medicine commonly used to treat non-productive cough and cold and flu symptoms in adults and children.

The recall is due to the potential drug interaction between Pholcodine and Neuromuscular Blocking Agent, a commonly used drug during general anesthesia that can cause anaphylaxis if the patient has taken Pholcodine containing products within the past 12 months. Anaphylaxis is a severe and life-threatening allergic reaction.

Alpro Pharmacy is committed to ensuring the safety and wellbeing of its customers and encourages those who have purchased Pholcodine medication to return it to the pharmacy or healthcare facility that supplied it. Consumers who have taken Pholcodine medicine in the past 12 months are advised to visit their nearest community pharmacy to prepare a medication list for their surgeon or doctor when surgery is required. For those who are uncertain if their medicine contains Pholcodine, Alpro Pharmacy offers a walk-in consultation at their nearest community pharmacy or contact their ePharmacy service for further assistance.

As an alternative to Pholcodine, Alpro Pharmacy offers a range of dry cough medication options. Consumers are welcome to visit any Alpro Pharmacy outlets or speak to their professional pharmacists via the ePharmacy WhatsApp hotline at 019-702 1923. The community pharmacist can recommend a suitable medication based on the patient’s health condition.

Alpro Pharmacy emphasizes the importance of medication safety and encourages the public to take proactive steps to ensure their wellbeing.